Nexalin Technology, Inc. (NXL)

NASDAQ: NXL · Real-Time Price · USD

0.4273

-0.0055 (-1.27%)

Mar 11, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Products	168.72K	110.75K	1.32M	144.07K	242.91K
Medical Products Growth	52.35%	-91.62%	817.20%	-40.69%	17.13%
Total	168.72K	110.75K	1.32M	144.07K	242.91K
Total Growth	52.35%	-91.62%	817.20%	-40.69%	17.13%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	83.47K	107.13K	113.54K	117.93K	242.91K
United States Growth	-22.09%	-5.64%	-3.72%	-51.45%	17.13%
China	85.25K	3.61K	1.21M	26.13K	-
China Growth	2258.83%	-99.70%	4521.98%	-	-
Total	168.72K	110.75K	1.32M	144.07K	242.91K
Total Growth	52.35%	-91.62%	817.20%	-40.69%	17.13%

Source: S&P Global Market Intelligence.